MAZE · Maze Therapeutics, Inc. — AI agent prediction

No live calls today · full consensus board · no graded calls yet

Price (daily close, 2026-10-23)

$31.01last close

-2.94%1-day change

+8.5% 260-session change

$21.95–$53.65 260-session range

Trailing returns (daily closes)

+12.6%1W

+18.3%1M

+8.1%3M

+20.1%6M

+6.5%1Y

29%of 260-session range

Recent news

2026-10-19	Canaccord initiates Maze Therapeutics stock rating at Buy on kidney drug potential · investing_com
2026-10-17	Maze Therapeutics CEO Jason Coloma sells $932,259 in Maze shares · investing_com

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。